Hamilton Lane Advisors LLC Denali Therapeutics Inc. Transaction History

Hamilton Lane Advisors LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 17, 2024	BUY	$14.96 - $23.22 $383,828 - $595,755	25,657 New	25,657 $595,000
Q2 2023 Jun 03, 2024	BUY	$23.37 - $32.96 $1.22 Million - $1.72 Million	52,129 New	52,129 $1.54 Million
Q2 2023 Aug 08, 2023	BUY	$23.37 - $32.96 $1.22 Million - $1.72 Million	52,129 New	52,129 $1.54 Million
Q4 2021 Jan 28, 2022	SELL	$42.59 - $55.02 $16.9 Million - $21.8 Million	-396,944 Closed	0 $0
Q3 2021 Oct 14, 2021	BUY	$48.48 - $78.23 $19.2 Million - $31.1 Million	396,944 New	396,944 $20 Million
Q2 2021 Jul 20, 2021	SELL	$50.3 - $78.44 $4.9 Million - $7.64 Million	-97,370 Closed	0 $0
Q1 2021 May 05, 2021	BUY	$53.8 - $81.53 $5.24 Million - $7.94 Million	97,370 New	97,370 $5.56 Million
Q4 2019 Jan 31, 2020	SELL	$14.4 - $19.99 $445,651 - $618,650	-30,948 Closed	0 $0
Q3 2019 Nov 13, 2019	BUY	$15.32 - $21.92 $474,123 - $678,380	30,948 New	30,948 $474,000

227

119M

60.6K

48.4K

Ticker DNLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 134,174,000
Market Cap $2.88B
Description
Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...

Get notified when there are updates to the investment portfolio of Hamilton Lane Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Hamilton Lane Advisors LLC with notifications on news.